STAT1 and neoplasm: Combined, these studies demonstrate a complex role for IFN/STAT1 signaling in tumor development and immune evasion, highlighting the need for further research to identify whether activation of this pathway will potentiate and/or suppress sensitivity to immune checkpoint inhibitors, alone or in combination with kinase inhibitors.